Violeta Serra, Guillermo Villacampa, Judith Balmaña
VIEW MORE
Published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), results of a VHIO-led study...
The promise of RAD51 testing in tailoring treatment strategies in early breast cancer
VIEW MORE
Led by Thierry Andre, Head of the Department of Medical Oncology at the Hôpital Saint Antoine in Paris, the phase...
First-line immunotherapy combination improves outcomes in patients with metastatic colorectal cancer versus chemotherapy
Cristina Saura
VIEW MORE
Recently published in The New England Journal of Medicine1 results of a phase 3, double-blind, randomized trial show that the...
Addition of PI3K inhibition could improve outcomes in patients with PIK3CA-mutated metastatic breast cancer

Latest News

Violeta Serra, Guillermo Villacampa, Judith Balmaña

Published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), results of a VHIO-led study...

The promise of RAD51 testing in tailoring treatment strategies in early breast cancer
Published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), results of a VHIO-led study...

Led by Thierry Andre, Head of the Department of Medical Oncology at the Hôpital Saint Antoine in Paris, the phase...

First-line immunotherapy combination improves outcomes in patients with metastatic colorectal cancer versus chemotherapy
Led by Thierry Andre, Head of the Department of Medical Oncology at the Hôpital Saint Antoine in Paris, the phase...
Cristina Saura

Recently published in The New England Journal of Medicine1 results of a phase 3, double-blind, randomized trial show that the...

Addition of PI3K inhibition could improve outcomes in patients with PIK3CA-mutated metastatic breast cancer
Recently published in The New England Journal of Medicine1 results of a phase 3, double-blind, randomized trial show that the...
Elena Garralda VHIO

The journal Nature has published the results of a clinical trial led by researchers from the Clínica Universidad de Navarra...

Blocking the GDF-15 protein may rescue resistance to immunotherapy against solid tumours
The journal Nature has published the results of a clinical trial led by researchers from the Clínica Universidad de Navarra...

PRINCIPAL RESEARCHERS

Diseño sin título (16)
Cristina Saura
Breast Cancer & Melanoma Group

The main area of expertise of the Breast Cancer Group is clinical research focused on drug development and associated translational…

Dr. Elena Garralda UITM Caixa Research VHIO
Elena Garralda
Early Clinical Drug Development Group

We focus on proof-of-concept and proof-of-mechanism trials with targeted therapies, with particular emphasis on cell signaling, cancer stem cells, and…

Teresa Macarulla VHIO
Teresa Macarulla
Gastrointestinal and Endocrine Tumors Group

Our group continues to play an essential role in developing molecular therapies against GI malignancies. We make important contributions to…

VHIO Alena Gros
Alena Gros
Tumor Immunology and Immunotherapy Group

Our group focuses on better understanding the naturally occurring T-cell response to cancer and establishing ways to exploit these antitumor…

Events

Privacy Preferences
When you visit our website, it may store information through your browser from specific services, usually in form of cookies. Here you can change your privacy preferences. Please note that blocking some types of cookies may impact your experience on our website and the services we offer.